NOVEMBER - 20225TECH OUTLOOKThree C's to Enable Continuous Development and Manufacturing for Small Molecule Active Pharmaceutical IngredientIN MY OPINIONNick Thomson, Senior Director, Chemical Research & Development, Pfizer [NYSE:PFE]08CXO INSIGHTSCloud Computing Driving Change in Pharma IndustryChris Braithwaite, SVP and Global Head of Drug Development Technology, Novartis19PCI ­ Expanding its European Biotech Footprint Chris Dobbs, CEng, MIET, Head of Technical Engineering, PCI Pharma Services22Developing Patient-Centric Precision Oncology Therapies: Begin With the End in MindSanjay Konagurthu, Senior Director, Science and Innovation, Pharma Services, Thermo Fisher Scientific26Impact of Advanced Manufacturing Technologies on the Pharmaceutical IndustryAtul Dubey, Director, Pharmaceutical Continuous Manufacturing, US Pharmacopeia28C O N TE N TSLAST WORDLeveraging AI/ML to Transform Pharmaceutical IndustryAlexander Bernikov, Medical Director, Clinical Development (Uro)-Oncology, Jiangsu Hengrui Pharmaceuticals30
< Page 4 | Page 6 >